Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ras GAP Inhibitors

Ras GAP inhibitors constitute a distinct chemical class of compounds designed to interact with proteins involved in the Ras signaling pathway. Ras proteins, primarily HRAS, NRAS, and KRAS, are essential regulators of cellular processes, including cell growth, proliferation, and differentiation. They operate as molecular switches, transitioning between an active, GTP-bound state and an inactive, GDP-bound state. The transition between these states is tightly regulated by a group of proteins, one of which is Ras GTPase-activating proteins (Ras GAPs). Ras GAPs play a pivotal role in switching off Ras signaling by accelerating the hydrolysis of GTP (guanosine triphosphate) to GDP (guanosine diphosphate) on Ras, effectively rendering it inactive. Chemically, Ras GAP inhibitors encompass a variety of small molecules and compounds with distinct mechanisms of action. Some of these compounds interfere with the prenylation of Ras proteins, which is a crucial post-translational modification essential for their membrane localization and activation. By blocking the prenylation process, Ras GAP inhibitors prevent Ras from properly localizing to the cell membrane, thus impeding its activation. Others inhibit enzymes like farnesyltransferase or geranylgeranyltransferase, which facilitate Ras prenylation. Additionally, covalent inhibitors have been developed to target specific mutant forms of Ras, such as the KRAS G12C mutant. These inhibitors form irreversible bonds with the mutant Ras proteins, locking them in an inactive conformation and preventing downstream signaling. Overall, Ras GAP inhibitors represent a diverse class of chemical agents with various strategies for disrupting Ras signaling, offering insights into the intricate regulation of cellular processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Arachidonic Acid-d8

69254-37-1sc-205209
sc-205209A
1 mg
5 mg
$233.00
$801.00
5
(0)

Arachidonic Acid-d8 serves as a potent ras gap, characterized by its ability to modulate GTPase activity through specific interactions with the ras protein. Its deuterated structure enhances stability and alters reaction kinetics, facilitating precise control over signaling pathways. The compound's unique hydrophobic regions promote effective membrane integration, influencing its interaction dynamics and enhancing the specificity of downstream effector recruitment. This specificity is crucial for regulating cellular responses.

Farnesyl thiosalicylic acid

162520-00-5sc-205322
sc-205322A
1 mg
5 mg
$60.00
$80.00
15
(1)

Farnesyl thiosalicylic acid is a small molecule Ras Gap inhibitor that interferes with Ras membrane localization by disrupting farnesylation, a post-translational modification necessary for Ras activation.

Tipifarnib

192185-72-1sc-364637
10 mg
$720.00
(0)

Tipifarnib is another farnesyltransferase inhibitor that prevents the farnesylation of Ras, thereby inhibiting its activity.

Lonafarnib

193275-84-2sc-482730
sc-482730A
5 mg
10 mg
$173.00
$234.00
(0)

Lonafarnib is a farnesyltransferase inhibitor.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$215.00
$622.00
5
(1)

Manumycin A is a natural compound that inhibits farnesyltransferase and, consequently, Ras activation. It has been explored as a potential anti-cancer agent.

Linsitinib

867160-71-2sc-396762
sc-396762A
5 mg
10 mg
$143.00
$260.00
1
(0)

While primarily known as an insulin-like growth factor 1 receptor (IGF-1R) inhibitor, Linsitinib can indirectly affect Ras signaling by targeting upstream pathways involved in Ras activation.